BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31916312)

  • 1. Novel classifiers with clinical laboratory parameters for early detection of osteosarcoma.
    Cao LL; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T
    J Clin Lab Anal; 2020 May; 34(5):e23189. PubMed ID: 31916312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma.
    Kim SH; Shin KH; Moon SH; Jang J; Kim HS; Suh JS; Yang WI
    Cancer Med; 2017 Jun; 6(6):1311-1322. PubMed ID: 28493412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High serum alkaline phosphatase cooperating with MMP-9 predicts metastasis and poor prognosis in patients with primary osteosarcoma in Southern China.
    Han J; Yong B; Luo C; Tan P; Peng T; Shen J
    World J Surg Oncol; 2012 Feb; 10():37. PubMed ID: 22333159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
    Ma B; Li M; Zhang L; Huang M; Lei JB; Fu GH; Liu CX; Lai QW; Chen QQ; Wang YL
    Tumour Biol; 2016 Apr; 37(4):4445-55. PubMed ID: 26499949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Classifier Based on Laboratory Indicators for Early Diagnosis and Prognosis Prediction of Ewing's Sarcoma.
    Cao LL; Yang L; Chen Z; Yue Z; Pei L; Jia M; Wang H; Li T
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
    Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
    Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone-specific alkaline phosphatase in plasma as tumour marker for osteosarcoma.
    Liu PP; Leung KS; Kumta SM; Lee KM; Fung KP
    Oncology; 1996; 53(4):275-80. PubMed ID: 8692530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Biomarkers for Osteosarcoma Based on Integration Strategy.
    Bao J; Song Z; Song C; Wang Y; Li W; Mai W; Shi Q; Yu H; Ni L; Liu Y; Lu X; He C; Chen L; Qu G
    Med Sci Monit; 2020 Mar; 26():e920803. PubMed ID: 32173717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel assessment method of serum alkaline phosphatase for the diagnosis of osteosarcoma in children and adolescents.
    Shimose S; Kubo T; Fujimori J; Furuta T; Ochi M
    J Orthop Sci; 2014 Nov; 19(6):997-1003. PubMed ID: 25100572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of circulating miR-663a as a potential biomarker for diagnosing osteosarcoma.
    Huang C; Sun Y; Ma S; Vadamootoo AS; Wang L; Jin C
    Pathol Res Pract; 2019 Jun; 215(6):152411. PubMed ID: 30987831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
    Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
    Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
    Gu R; Sun Y
    J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding MT1JP Enhanced the Inhibitory Effects of miR-646 on FGF2 in Osteosarcoma.
    Yang L; Liu G; Xiao S; Wang L; Liu X; Tan Q; Li Z
    Cancer Biother Radiopharm; 2020 Jun; 35(5):371-376. PubMed ID: 32196384
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum CEACAM1 Level Is Associated with Diagnosis and Prognosis in Patients with Osteosarcoma.
    Yu H; Yu J; Ren Y; Yang Y; Xiao X
    PLoS One; 2016; 11(4):e0153601. PubMed ID: 27074014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel prognostic model for osteosarcoma using circulating CXCL10 and FLT3LG.
    Flores RJ; Kelly AJ; Li Y; Nakka M; Barkauskas DA; Krailo M; Wang LL; Perlaky L; Lau CC; Hicks MJ; Man TK
    Cancer; 2017 Jan; 123(1):144-154. PubMed ID: 27529817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of osteosarcoma-related specific proteins in serum samples using surface-enhanced laser desorption/ionization-time-of-flight mass spectrometry.
    Gu J; Li J; Huang M; Zhang Z; Li D; Song G; Ding X; Li W
    J Immunol Res; 2014; 2014():649075. PubMed ID: 24872957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three hematological indexes that may serve as prognostic indicators in patients with primary, high-grade, appendicular osteosarcoma.
    Hu K; Wang Z; Lin P; Wen Z; Ren H; Sun L; Li H; Li B; Wang S; Zhou X; Tengwang S; Xu L; Ye Z
    Oncotarget; 2017 Jun; 8(26):43130-43139. PubMed ID: 28562345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of circulating serum amyloid A and CXC chemokine ligand 4 in osteosarcoma.
    Flores RJ; Kelly AJ; Li Y; Chen X; McGee C; Krailo M; Barkauskas DA; Hicks J; Man TK
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28544777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of circulating long non-coding RNA UCA1 as potential biomarkers for diagnosis and prognosis of osteosarcoma.
    Wen JJ; Ma YD; Yang GS; Wang GM
    Eur Rev Med Pharmacol Sci; 2017 Feb; 21(3):498-503. PubMed ID: 28239821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.